Search Results 1091-1100 of 18427 for prednisone

1. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Treatment with oral or parenteral corticosteroids dosed greater than 40 mg hydrocortisone daily or its equivalent (e.g., prednisone 10 mg, prednisolone 8 mg ...

2. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   ... prednisone or equivalent (unless administered to prevent contrast material reactions during radiographic procedures), or growth factor treatment (e.g. ...

3. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE) - Mayo Clinic

   ... prednisone >10 mg/day or equivalent, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [TNF]-alpha agents) =< 7 days ...

4. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   Systemic therapy with corticosteroids at >20 mg/day prednisone or equivalent within 1 week prior to the first dose of study drug; History of another invasive ...

5. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Received an oral daily dose of a GC of more than 10 mg prednisone-equivalent for more than 6 weeks continuously prior to screening. Received CD20 inhibitor ...

6. Ciprofloxacin and dexamethasone (otic route) - Side effects & dosage - Mayo Clinic

   Description. Ciprofloxacin and dexamethasone combination ear drops is used to treat ear infections, such as acute otitis externa and acute otitis media.

7. A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases - Mayo Clinic

   If using prednisone, participants must be on stable dose for ≥4 weeks prior to Visit 2; If using rituximab, participants must have completed their first ...

8. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

   Continuous systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 2 weeks prior ...

9. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

   ... prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication * Has a known additional ...

10. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    ... prednisone, thioguanine, vincristine, ... FT819 in Subjects With B-cell Malignancies Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. The purpose of ...